Combined hepatocellular carcinoma and cholangiocarcinoma

MONDO:0044791

A rare tumor containing unequivocal elements of both hepatocellular and cholangiocarcinoma that are intimately admixed. This tumor should be distinguished from separate hepatocellular carcinoma and cholangiocarcinoma arising in the same liver. The prognosis of this tumor is poor.

Also known as: carcinoma of liver and intrahepatic biliary tract, liver and intrahepatic biliary tract carcinoma, Cholangiohepatoma, Hepatocholangiocarcinoma, Mixed hepatocellular cholangiocarcinoma, carcinoma of the liver and intrahepatic biliary tract, combined hepatocellular cancer and cholangiocarcinoma (bile duct cancer), combined hepatocellular cancer and intrahepatic bile duct cancer (cholangiocarcinoma)

2972 clinical trials for this condition and its sub-types, 8 tagged with Combined hepatocellular carcinoma and cholangiocarcinoma itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Adenocarcinoma of gallbladder and extrahepatic biliary tract (374)

Including sub-types (2972) Tagged with Combined hepatocellular carcinoma and cholangiocarcinoma (8)

Trials to join now! 2 Not yet recruiting 2 Not yet finished but already full! 3 Completed 1

Old gout drug tested as new hope for advanced liver cancer

Disease control Completed

This phase 2 trial tested colchicine, a drug usually used for gout, in 42 people with advanced liver cancer that could not be treated with curative intent. Participants took colchicine tablets daily in cycles of 4 days on, 3 days off. The study measured how long patients survived…

Phase 2 • Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital • Aim: Disease control

Last updated Jun 26, 2026 14:59 UTC

Combined hepatocellular carcinoma and cholangiocarcinoma

Where it sits in the disease tree

Old gout drug tested as new hope for advanced liver cancer